Warning! GuruFocus detected
1 Severe warning sign
with RPHM.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Reneo Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US75974E1038
Compare
Compare
Traded in other countries / regions
RPHM.USA Index Membership
Russell 2000Russell 2000Russell 3000 IPO Date
2021-04-09Description
Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 93.16 | |||||
| Equity-to-Asset | 0.98 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -49.6 | |||||
| 3-Year EPS without NRI Growth Rate | -46.3 | |||||
| 3-Year FCF Growth Rate | -39.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 80.83 | |||||
| 9-Day RSI | 74.84 | |||||
| 14-Day RSI | 69.89 | |||||
| 3-1 Month Momentum % | -5.3 | |||||
| 6-1 Month Momentum % | -17.34 | |||||
| 12-1 Month Momentum % | -80.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 57.86 | |||||
| Quick Ratio | 57.86 | |||||
| Cash Ratio | 56.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.3 | |||||
| Shareholder Yield % | 0.63 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -57.2 | |||||
| ROA % | -51.47 | |||||
| ROIC % | -1619.82 | |||||
| 3-Year ROIIC % | -1583.96 | |||||
| ROC (Joel Greenblatt) % | -5693.68 | |||||
| ROCE % | -61.87 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.79 | |||||
| Price-to-Tangible-Book | 0.79 | |||||
| EV-to-EBIT | 0.24 | |||||
| EV-to-EBITDA | 0.24 | |||||
| EV-to-FCF | 0.23 | |||||
| Price-to-Net-Current-Asset-Value | 0.8 | |||||
| Price-to-Net-Cash | 0.81 | |||||
| Earnings Yield (Greenblatt) % | 416.67 | |||||
| FCF Yield % | -109.11 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RPHM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Reneo Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -16.9 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.1 | ||
| 3-Year Sortino Ratio | 0.17 | ||
| Volatility % | 79.82 | ||
| 14-Day RSI | 69.89 | ||
| 14-Day ATR ($) | 1.21758 | ||
| 20-Day SMA ($) | 15.23 | ||
| 12-1 Month Momentum % | -80.54 | ||
| 52-Week Range ($) | 9.801 - 92.1 | ||
| Shares Outstanding (Mil) | 33.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Reneo Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Reneo Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Reneo Pharmaceuticals Inc Frequently Asked Questions
What is Reneo Pharmaceuticals Inc(RPHM)'s stock price today?
The current price of RPHM is $18.20. The 52 week high of RPHM is $92.10 and 52 week low is $9.80.
When is next earnings date of Reneo Pharmaceuticals Inc(RPHM)?
The next earnings date of Reneo Pharmaceuticals Inc(RPHM) is 2025-05-07 Est..
Does Reneo Pharmaceuticals Inc(RPHM) pay dividends? If so, how much?
Reneo Pharmaceuticals Inc(RPHM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers